Data Insights
No Filter Selected
No Filter Selected
No Filter Selected
No Filter Selected
TQH-2722 by Chia Tai Tianqing Pharmaceutical Group for Rhinosinusitis: Likelihood of Approval
TQH-2722 is under clinical development by Chia Tai Tianqing Pharmaceutical Group and currently in Phase II for Rhinosinusitis. According to...
TQH-2722 by Chia Tai Tianqing Pharmaceutical Group for Nasal Polyps (Nasal Polyposis): Likelihood of Approval
TQH-2722 is under clinical development by Chia Tai Tianqing Pharmaceutical Group and currently in Phase II for Nasal Polyps (Nasal...
TQH-2722 by Chia Tai Tianqing Pharmaceutical Group for Sinusitis: Likelihood of Approval
TQH-2722 is under clinical development by Chia Tai Tianqing Pharmaceutical Group and currently in Phase II for Sinusitis. According to...